Skip to main content
SpringerLink
Log in
Book cover

Reproductive Endocrinology and Infertility pp 71–92Cite as

Successfully Integrating the FDA Regulations into Your Practice

  • Chapter
  • First Online:

  • 2897 Accesses

Abstract

The fertility field has had its challenges with regard to state and federal regulations over the past 20 years. In 2005, ART programs were faced with a new regulatory challenge - the Food and Drug Administration. The ruling entitled “21 CFR Part 1271 Human Cells, Tissues, and Cellular and Tissue-Based Products” regulates non-vascularized human tissues including reproductive tissues and touches on donor and non-donor tissues affecting the clinical, as well as the laboratory areas of an ART program. This chapter examines the history of ART regulation, defines the scope of what is regulated for ART programs, and describes the most important aspects of the ruling that medical and laboratory directors need to know for compliance. In addition, practical “field-tested” information from a fertility perspective is given on how to develop and maintain a compliance program specifically focused on dealing with the 21 CFR Part 1271 ruling. Finally, case examples from real donor situations are described in order to test the reader’s knowledge and comprehension of the regulations as applied to an ART program.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    Note: see “Subpart E: Additional requirements” for explanation on how 1271.370 is important for labeling

References

  1. Henkel J (1994) Safeguarding human tissue transplants. FDA Consum 28(7):9-13

    CAS  PubMed  Google Scholar 

  2. U.S. Department of Health and Human Services; Food and Drug Administration (2003) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; establishment registration and listing; final rule; delay of effective date. Fed Regist 68(13):2689-2691

    Google Scholar 

  3. U.S. Department of Health and Human Services; Food and Drug Administration (2004) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; establishment registration and listing; interim final rule; opportunity for public comment. Fed Regist 69(17):3823-3826

    Google Scholar 

  4. U.S. Department of Health and Human Services; Food and Drug Administration (2001) 21 CFR parts 207, 807, and 1271: human cells, tissues, and cellular and tissue-based products; establishment registration and listing; final rule. Fed Regist 66(13):5447-5469

    Google Scholar 

  5. U.S. Department of Health and Human Services; Food and Drug Administration (2004) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; establishment registration and listing; correction. Fed Regist 69(23):5272

    Google Scholar 

  6. U.S. Department of Health and Human Services; Food and Drug Administration (2008) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; CFR correction to 1271.22. Fed Regist 73(13):3387

    Google Scholar 

  7. U.S. Department of Health and Human Services; Food and Drug Administration (2005) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling; interim final rule; opportunity for public comment. Fed Regist 70(100):29949-29952

    Google Scholar 

  8. U.S. Department of Health and Human Services; Food and Drug Administration (2006) 21 CFR part 1271: eligibility determination for donors of human cells, tissue, and cellular and tissue-based products; correction. Fed Regist 71(57):14798

    Google Scholar 

  9. U.S. Department of Health and Human Services; Food and Drug Administration (2004) 21 CFR parts 210, 211, 820, and 1271: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products; final rule and notice. Fed Regist 69(101):29786-29834

    Google Scholar 

  10. U.S. Department of Health and Human Services; Food and Drug Administration (2004) 21 CFR parts 16, 1270, and 1271: current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement; final rule. Fed Regist 69(226):68612-68688

    Google Scholar 

  11. U.S. Department of Health and Human Services; Food and Drug Administration (2007) 21 CFR part 1271: human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling; final rule. Fed Regist 72(117):33667-33669

    Google Scholar 

  12. Department of Health and Human Services (1992) Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) - HCFA. Final rule with comment period. Fed Regist 57(40):7002-7186

    Google Scholar 

  13. Department of Health and Human Services (1993) Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Clinical Laboratory Improvement Act Program fee collection - HCFA. Final rule with comment period. Fed Regist 58(11):5215-5237

    Google Scholar 

  14. Department of Health and Human Services; Centers for Disease Control and Prevention (1999) Implementation of the fertility clinic success rate and certification act of 1992 - a model program for the certification of embryo laboratories; notice. Fed Regist 64(139):39374-39392

    Google Scholar 

  15. Critser J (1998) Current status of semen banking in the USA. Hum Reprod 13(Suppl. 2):55-67 Discussion 68-9

    PubMed  Google Scholar 

  16. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps).

    Google Scholar 

  17. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 14-21

    Google Scholar 

  18. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 24-5

    Google Scholar 

  19. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 21-4

    Google Scholar 

  20. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 23

    Google Scholar 

  21. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 13

    Google Scholar 

  22. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 31-7

    Google Scholar 

  23. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 33-4

    Google Scholar 

  24. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 37-8

    Google Scholar 

  25. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2006) Guidance for industry: compliance with 21 CFR Part 1271.150(c)(1) - manufacturing arrangements.

    Google Scholar 

  26. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 28-31

    Google Scholar 

  27. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 58-61

    Google Scholar 

  28. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 40-2

    Google Scholar 

  29. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: certain human cells, tissues, and cellular and tissue-based products (HCT/Ps) recovered from donors who were tested for communicable diseases using pooled specimens or diagnostic tests.

    Google Scholar 

  30. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 7

    Google Scholar 

  31. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps); small entity compliance guide. 11

    Google Scholar 

  32. Malarkey M. HCT/P Compliance update. 2008 Jan 10 [cited 2008 Feb 25]. Available from: http://www.fda.gov/cber/summaries/hctp010808mm.pdf

  33. Wells M FDA update: relevant to reproductive establishments. 2007 Sep 17 [cited 2008 Feb 29]. Available from: http://www.fda.gov/cber/tissue/aatb091707mw.pdf

  34. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 41

    Google Scholar 

  35. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps); small entity compliance guide.

    Google Scholar 

  36. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 19

    Google Scholar 

  37. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Biologics Evaluation and Research (2007) Guidance for industry: eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 31

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jade Tree Solutions, LLC, 1302, Northbrook, IL, 60062, USA

    Wendy D. Latash

Authors
  1. Wendy D. Latash
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wendy D. Latash .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Utah, Arapeen Dr. 675, Salt Lake City, 84108, USA

    Douglas T. Carrell

  2. School of Medicine, University of Utah, North Medical Drive 50, Salt Lake City, 84132, USA

    C. Matthew Peterson

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Latash, W.D. (2010). Successfully Integrating the FDA Regulations into Your Practice. In: Carrell, D., Peterson, C. (eds) Reproductive Endocrinology and Infertility. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1436-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1436-1_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1435-4

  • Online ISBN: 978-1-4419-1436-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation